ATE329581T1 - Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet - Google Patents
Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltetInfo
- Publication number
- ATE329581T1 ATE329581T1 AT03700915T AT03700915T ATE329581T1 AT E329581 T1 ATE329581 T1 AT E329581T1 AT 03700915 T AT03700915 T AT 03700915T AT 03700915 T AT03700915 T AT 03700915T AT E329581 T1 ATE329581 T1 AT E329581T1
- Authority
- AT
- Austria
- Prior art keywords
- dry granulation
- pharmaceutical composition
- oxazino
- piperidinyl
- indole
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 150000003839 salts Chemical class 0.000 title abstract 5
- 238000007908 dry granulation Methods 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 6
- 239000008187 granular material Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- KVCSJPATKXABRQ-UHFFFAOYSA-N piboserod Chemical compound C1CN(CCCC)CCC1CNC(=O)C(C1=CC=CC=C11)=C2N1CCCO2 KVCSJPATKXABRQ-UHFFFAOYSA-N 0.000 abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 235000019700 dicalcium phosphate Nutrition 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229950007988 piboserod Drugs 0.000 abstract 1
- 238000009490 roller compaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0203526A GB0203526D0 (en) | 2002-02-14 | 2002-02-14 | Process and composition |
| GB0203528A GB0203528D0 (en) | 2002-02-14 | 2002-02-14 | Process and composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329581T1 true ATE329581T1 (de) | 2006-07-15 |
Family
ID=27736214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03700915T ATE329581T1 (de) | 2002-02-14 | 2003-01-22 | Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050075335A1 (de) |
| EP (1) | EP1476136B1 (de) |
| JP (1) | JP2005523276A (de) |
| KR (1) | KR100967782B1 (de) |
| AT (1) | ATE329581T1 (de) |
| AU (1) | AU2003202058B2 (de) |
| BR (1) | BR0307666A (de) |
| CA (1) | CA2475659A1 (de) |
| CO (1) | CO5611095A2 (de) |
| CY (1) | CY1106148T1 (de) |
| DE (1) | DE60306120T2 (de) |
| DK (1) | DK1476136T3 (de) |
| ES (1) | ES2263949T3 (de) |
| IS (1) | IS2393B (de) |
| MX (1) | MXPA04007857A (de) |
| NO (1) | NO20043834L (de) |
| NZ (1) | NZ534333A (de) |
| PL (1) | PL206544B1 (de) |
| PT (1) | PT1476136E (de) |
| RU (1) | RU2329789C2 (de) |
| WO (1) | WO2003068193A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211230D0 (en) * | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| CA2406592C (en) * | 2002-10-04 | 2003-09-30 | Duchesnay Inc. | Method of preparing pharmaceutical dosage forms containing multiple active ingredients |
| PE20060373A1 (es) | 2004-06-24 | 2006-04-29 | Smithkline Beecham Corp | Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| CN101437492A (zh) * | 2006-05-04 | 2009-05-20 | 诺瓦提斯公司 | 用于制备药物组合物的热滚压法 |
| AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| SI2170292T1 (sl) * | 2007-06-22 | 2014-05-30 | Bristol-Myers Squibb Holdings Ireland | Tabletirani sestavki, ki vsebujejo atazanavir |
| ES2686081T3 (es) * | 2007-07-31 | 2018-10-16 | Cargill, Incorporated | Dextrosa comprimible directamente |
| EP2406249A1 (de) | 2009-03-10 | 2012-01-18 | Glaxo Group Limited | Indolderivate als ikk2-inhibitoren |
| TW201129386A (en) * | 2009-11-05 | 2011-09-01 | Fmc Corp | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| TWI461213B (zh) * | 2009-11-05 | 2014-11-21 | Fmc Corp | 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物 |
| RU2564922C2 (ru) * | 2011-04-19 | 2015-10-10 | Григорий Яковлевич ЛЕГИН | Композиция для изготовления спороцидных композиций надуксусной кислоты, способ (варианты) и набор для его осуществления |
| US9606054B2 (en) | 2013-09-30 | 2017-03-28 | Advantest Corporation | Methods, sampling device and apparatus for terahertz imaging and spectroscopy of coated beads, particles and/or microparticles |
| US9417181B2 (en) | 2014-05-08 | 2016-08-16 | Advantest Corporation | Dynamic measurement of density using terahertz radiation with real-time thickness measurement for process control |
| WO2016126012A1 (en) * | 2015-02-05 | 2016-08-11 | Boryung Pharmaceutical Co., Ltd | Tablet and method of preparing the same |
| KR101545268B1 (ko) | 2015-02-05 | 2015-08-20 | 보령제약 주식회사 | 정제 및 이의 제조방법 |
| CN104945303B (zh) * | 2015-06-15 | 2017-09-29 | 浙江工业大学 | 3‑烯基吲哚类化合物的制备方法 |
| KR20230005270A (ko) | 2020-04-24 | 2023-01-09 | 아스트라제네카 아베 | 약학적 제형 |
| KR102499289B1 (ko) * | 2022-04-15 | 2023-02-14 | 주식회사 비에스앤코 | 가루치약의 제조방법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3134719A (en) * | 1962-04-05 | 1964-05-26 | American Cyanamid Co | Calcium phosphates in tablet compressing |
| US5066441A (en) * | 1980-12-12 | 1991-11-19 | Rhone-Poulenc Basic Chemicals Co. | Process for compacting a calcium phosphate composition |
| US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
| US4713245A (en) * | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
| US5055307A (en) * | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
| US5861172A (en) * | 1991-05-08 | 1999-01-19 | Laboratorios Beecham Sa | Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
| US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
| SG50693A1 (en) * | 1992-03-12 | 1998-07-20 | Smithkline Beecham Plc | Pharmaceuticals |
| US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
| GB9408117D0 (en) * | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
| DE4418837A1 (de) * | 1994-05-30 | 1995-12-07 | Bayer Ag | Thermisches Granulierverfahren |
| FR2740357B1 (fr) * | 1995-10-25 | 1997-11-28 | Rhone Poulenc Chimie | Granules redispersables dans l'eau comprenant une matiere active sous forme liquide et un tensio-actif non ionique du type alcoxyles |
| CN1104435C (zh) * | 1996-08-16 | 2003-04-02 | 史密丝克莱恩比彻姆有限公司 | N－[(1－正丁基－4－哌啶基)甲基]－3,4－二氢－2H－[1,3] 噁嗪并[3,2－α]吲哚－10－甲酰胺及其盐的制备方法及在本方法中的中间体的制备方法 |
| JP2004505930A (ja) * | 2000-08-07 | 2004-02-26 | ラボラトワール・グラクソスミスクライン・ソシエテ・パール・アクシオン・シンプリフィエ | 心房細動の予防または治療のための薬物の製造における５ｈｔ４受容体アンタゴニストの使用 |
| AU2001276558B2 (en) * | 2000-08-08 | 2005-11-24 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising condensed indole compound |
| NZ535261A (en) * | 2000-08-08 | 2004-12-24 | Smithkline Beecham P | A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide |
| US6666298B2 (en) * | 2001-11-21 | 2003-12-23 | John Volkman | Hanging scaffold support |
-
2003
- 2003-01-22 RU RU2004127450/15A patent/RU2329789C2/ru not_active IP Right Cessation
- 2003-01-22 PL PL371963A patent/PL206544B1/pl not_active IP Right Cessation
- 2003-01-22 WO PCT/GB2003/000217 patent/WO2003068193A1/en not_active Ceased
- 2003-01-22 BR BR0307666-0A patent/BR0307666A/pt not_active IP Right Cessation
- 2003-01-22 CA CA002475659A patent/CA2475659A1/en not_active Abandoned
- 2003-01-22 NZ NZ534333A patent/NZ534333A/en not_active IP Right Cessation
- 2003-01-22 US US10/503,750 patent/US20050075335A1/en not_active Abandoned
- 2003-01-22 PT PT03700915T patent/PT1476136E/pt unknown
- 2003-01-22 DK DK03700915T patent/DK1476136T3/da active
- 2003-01-22 JP JP2003567377A patent/JP2005523276A/ja active Pending
- 2003-01-22 KR KR1020047012580A patent/KR100967782B1/ko not_active Expired - Fee Related
- 2003-01-22 DE DE60306120T patent/DE60306120T2/de not_active Expired - Lifetime
- 2003-01-22 AU AU2003202058A patent/AU2003202058B2/en not_active Ceased
- 2003-01-22 EP EP03700915A patent/EP1476136B1/de not_active Expired - Lifetime
- 2003-01-22 ES ES03700915T patent/ES2263949T3/es not_active Expired - Lifetime
- 2003-01-22 AT AT03700915T patent/ATE329581T1/de active
- 2003-01-22 MX MXPA04007857A patent/MXPA04007857A/es active IP Right Grant
-
2004
- 2004-08-11 CO CO04078329A patent/CO5611095A2/es not_active Application Discontinuation
- 2004-08-12 IS IS7398A patent/IS2393B/is unknown
- 2004-09-13 NO NO20043834A patent/NO20043834L/no not_active Application Discontinuation
-
2006
- 2006-08-28 CY CY20061101205T patent/CY1106148T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2263949T3 (es) | 2006-12-16 |
| DK1476136T3 (da) | 2006-10-09 |
| CO5611095A2 (es) | 2006-02-28 |
| EP1476136A1 (de) | 2004-11-17 |
| RU2004127450A (ru) | 2005-04-10 |
| JP2005523276A (ja) | 2005-08-04 |
| IS7398A (is) | 2004-08-12 |
| NZ534333A (en) | 2006-05-26 |
| EP1476136B1 (de) | 2006-06-14 |
| NO20043834L (no) | 2004-10-26 |
| CY1106148T1 (el) | 2011-06-08 |
| US20050075335A1 (en) | 2005-04-07 |
| RU2329789C2 (ru) | 2008-07-27 |
| AU2003202058A1 (en) | 2003-09-04 |
| BR0307666A (pt) | 2005-01-11 |
| AU2003202058B2 (en) | 2009-05-28 |
| DE60306120T2 (de) | 2006-11-09 |
| PT1476136E (pt) | 2006-10-31 |
| KR20040097996A (ko) | 2004-11-18 |
| PL371963A1 (en) | 2005-07-11 |
| HK1072359A1 (en) | 2005-08-26 |
| WO2003068193A1 (en) | 2003-08-21 |
| IS2393B (is) | 2008-08-15 |
| MXPA04007857A (es) | 2004-10-15 |
| DE60306120D1 (de) | 2006-07-27 |
| CA2475659A1 (en) | 2003-08-21 |
| PL206544B1 (pl) | 2010-08-31 |
| KR100967782B1 (ko) | 2010-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE329581T1 (de) | Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet | |
| RU2004135377A (ru) | Таблетки для рассасывания и способ их изготовления | |
| EA200900264A1 (ru) | Композиции флибансерина и способ их приготовления | |
| EA201001852A1 (ru) | Твердые фармацевтические составы, содержащие bibw 2992 | |
| CA2470601A1 (en) | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms | |
| IL187591A0 (en) | Pharmaceutical composition as solid dosage from and method for manufacturing thereof | |
| HRP20100399T1 (hr) | Oralno dezintegrirajući pripravak olanzapina ili donepezila | |
| NZ510583A (en) | Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative | |
| UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
| HRP20060136A2 (en) | Pellets containing venflaxine hydrochloride | |
| DK1501484T3 (da) | Fremgangsmåde til fremstilling af tabletter ud fra farmaceutisk aktive stoffer som har uönskede tabletteringsegenskabler, med en granuleringsvæske der omfatter mikrokrystallinsk cellulose | |
| CA2353693A1 (en) | Pharmaceutical composition containing citalopram | |
| IL200447A0 (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
| WO2007052307A3 (en) | Stable solid oral dosage forms of valsartan | |
| PL378106A1 (pl) | Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem | |
| WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
| MXPA05011591A (es) | Composicion farmaceutica como forma de dosificacion solida y metodo para la elaboracion de la misma. | |
| WO2005094893A3 (en) | Freeze-dried, free-flowing, particulate composition having improved palatability | |
| EA200901191A1 (ru) | Фармацевтическая композиция, содержащая активный ингредиент аторвастатин | |
| BRPI0418769A (pt) | composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima | |
| EA200600932A1 (ru) | Таблетки циталопрама гидробромида | |
| TW200503728A (en) | Suspension pharmaceutical composition containing budesonide and method for producing the same | |
| UA40999A (uk) | Спосіб одержання твердої фармацевтичної композиції |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1476136 Country of ref document: EP |